You are here

Home

Clinical Trials: Urological Disease

Comment

Discuss

Each Clinical Trial will open in a new browser window or tab.

Return to Clinical Trials Page

Posted: Friday, September 25, 2015 - 12:00
Effect of BM-MSCs in DCD Kidney Transplantation
Conditions:   Kidney Transplantation;   Acute Kidney Tubular Necrosis
Interventions:   Other: bone marrow-derived mesenchymal stem cells;   Other: Saline;   Drug: Induction therapy (ATG or Basiliximab);   Drug: Maintenance therapy (Low-dose CNI + MPA + steroids)
Sponsors:   First Affiliated Hospital, Sun Yat-Sen University;   Second Affiliated Hospital of Guangzhou Medical University
Not yet recruiting - verified September 2015
Posted: Thursday, September 24, 2015 - 12:00
MSC and Kidney Transplant Tolerance (Phase A)
Condition:   Chronic Renal Failure
Intervention:   Biological: Mesenchymal Stromal Cells
Sponsors:   Monia Lorini;   Mario Negri Institute for Pharmacological Research
Recruiting - verified September 2015
Posted: Thursday, July 30, 2015 - 12:00
Autologous Neo-Kidney Augment (NKA) in Patients With Type 2 Diabetes and Chronic Kidney Disease (CKD)
Conditions:   Chronic Kidney Disease;   Type 2 Diabetes
Intervention:   Biological: Neo-Kidney Augment
Sponsors:   RegenMed (Cayman) Ltd.;   CTI Clinical Trial and Consulting Services
Not yet recruiting - verified April 2016
Posted: Monday, June 8, 2015 - 12:00
Linagliptin Effect on CD34+ Stem Cells
Conditions:   Type 2 Diabetes;   Impaired Renal Function
Interventions:   Drug: Linagliptin;   Drug: Placebo
Sponsors:   George Washington University;   Boehringer Ingelheim
Recruiting - verified April 2015
Posted: Wednesday, May 20, 2015 - 12:00
Effect of SVF Derived MSC in DCD Renal Transplantation
Condition:   Uremia
Interventions:   Other: SVFderived MSC transplantations;   Drug: Basiliximab
Sponsor:   Fuzhou General Hospital
Recruiting - verified November 2014
Posted: Tuesday, March 3, 2015 - 12:00
Allogenic AD-MSC Transplantation in Idiopathic Nephrotic Syndrome (Focal Segmental Glomerulosclerosis)
Condition:   Focal Segmental Glomerulosclerosis
Intervention:   Biological: Intravenous injection
Sponsor:   Royan Institute
Recruiting - verified November 2015
Posted: Sunday, December 21, 2014 - 12:00
Stem Cell Therapy for Treatment of Female Stress Urinary Incontinence
Condition:   Urinary Incontinence, Stress
Interventions:   Biological: Stem Cells,Mesenchymal;   Procedure: surgery (TVT)
Sponsor:   Ain Shams Maternity Hospital
Recruiting - verified November 2015
Posted: Tuesday, November 11, 2014 - 12:00
Autologous Cell Therapy for Stress Urinary Incontinence in Males Following Prostate Surgery
Conditions:   Urinary Incontinence;   Stress;   Urination Disorders;   Urologic Diseases;   Lower Urinary Tract Symptoms;   Urological Manifestations
Intervention:   Biological: autologous muscle-derived cells (AMDC)
Sponsor:   Cook
Recruiting - verified April 2016
Posted: Thursday, September 18, 2014 - 12:00
Hypoxia and Inflammatory Injury in Human Renovascular Hypertension
Conditions:   Renal Artery Stenosis;   Ischemic Nephropathy;   Renovascular Disease;   Chronic Kidney Disease
Interventions:   Drug: Mesenchymal stem cell;   Procedure: Mesenchymal stem cell delivery with stent placement
Sponsors:   Mayo Clinic;   University of Mississippi Medical Center;   University of Alabama at Birmingham
Recruiting - verified October 2015
Posted: Wednesday, February 26, 2014 - 12:00
Transurethral Myoblast Injection for Urinary Incontinence in Children With Bladder Exstrophy
Condition:   Urinary Incontinence
Interventions:   Procedure: Myoblast Transplantation;   Biological: Neonatal Cystourethroscope Injection
Sponsors:   Al-Azhar University;   Cairo University;   Affiliated Hospital to Academy of Military Medical Sciences
Recruiting - verified February 2014

Pages